Histamine dihydrochloride and interleukin-2 in acute myeloid leukemia--background and results.
Brune
M
M
Department of Infectious Diseases, Sahlgrenska Academy, Göteborg University, Guldhedsgatan 10B, 413 46, Göteborg, Sweden.
Romero
A I
AI
Hellstrand
K
K
D002986:Clinical Trials as Topic; D018572:Disease-Free Survival; D004359:Drug Therapy, Combination; D006632:Histamine / Q000276:immunology / Q000627:therapeutic use*; D017442:Histamine Agonists / Q000276:immunology / Q000627:therapeutic use*; D006801:Humans; D007376:Interleukin-2 / Q000276:immunology / Q000627:therapeutic use*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000276:immunology; D012074:Remission Induction
D017442:Histamine Agonists; D007376:Interleukin-2; D006632:Histamine